China Medical System Holdings Limited

SHSC:867 Stock Report

Market Cap: HK$18.7b

China Medical System Holdings Future Growth

Future criteria checks 4/6

China Medical System Holdings is forecast to grow earnings and revenue by 21.4% and 14.7% per annum respectively. EPS is expected to grow by 21.9% per annum. Return on equity is forecast to be 15.4% in 3 years.

Key information

21.4%

Earnings growth rate

21.9%

EPS growth rate

Pharmaceuticals earnings growth10.8%
Revenue growth rate14.7%
Future return on equity15.4%
Analyst coverage

Good

Last updated02 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:867 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610,4092,5892,7612,6758
12/31/20258,9382,0392,0361,93810
12/31/20247,8361,7661,9861,88610
6/30/20247,0141,3901,2351,885N/A
3/31/20247,5141,8961,7172,194N/A
12/31/20238,0132,4012,2002,503N/A
9/30/20238,6632,8912,6153,047N/A
6/30/20239,3133,3813,0313,592N/A
3/31/20239,2323,3203,0293,573N/A
12/31/20229,1503,2593,0283,553N/A
9/30/20229,0463,2242,6983,032N/A
6/30/20228,9423,1892,3672,511N/A
3/31/20228,6403,1032,3382,502N/A
12/31/20218,3373,0172,3092,494N/A
9/30/20218,0092,9482,3732,591N/A
6/30/20217,6812,8782,4372,688N/A
3/31/20217,3132,7042,3942,690N/A
12/31/20206,9462,5302,3512,692N/A
9/30/20206,5822,3002,2862,661N/A
6/30/20206,2172,0702,2222,631N/A
3/31/20206,1452,0152,2182,593N/A
12/31/20196,0741,9612,2152,555N/A
9/30/20195,9082,0112,0872,344N/A
6/30/20195,7432,0621,9602,132N/A
3/31/20195,5881,9561,8291,943N/A
12/31/20185,4331,8501,6981,755N/A
9/30/20185,3751,8391,8131,875N/A
6/30/20185,3171,8271,9281,996N/A
3/31/20185,3331,751N/A2,034N/A
12/31/20175,3491,675N/A2,072N/A
9/30/20175,3791,601N/A1,876N/A
6/30/20175,4101,527N/A1,679N/A
3/31/20175,1551,452N/A1,421N/A
12/31/20164,9011,376N/A1,162N/A
9/30/20164,4771,265N/A1,134N/A
6/30/20164,0541,155N/A1,105N/A
3/31/20163,8041,075N/A860N/A
12/31/20153,553996N/A615N/A
9/30/20153,4041,062N/A528N/A
6/30/20153,2551,128N/A441N/A
3/31/20153,1001,087N/A642N/A
12/31/20142,9451,046N/A843N/A
9/30/20142,760890N/A689N/A
6/30/20142,575734N/A535N/A
3/31/20142,412685N/A435N/A
12/31/20132,249636N/A335N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 867's forecast earnings growth (21.4% per year) is above the savings rate (2.3%).

Earnings vs Market: 867's earnings (21.4% per year) are forecast to grow faster than the Hong Kong market (11.4% per year).

High Growth Earnings: 867's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 867's revenue (14.7% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 867's revenue (14.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 867's Return on Equity is forecast to be low in 3 years time (15.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y